International law firm Bird & Bird has been advising European pharmaceutical company, Archimedes Pharma Ltd (“Archimedes”), on the intellectual property issues relating to their acquisition of Link Holdings Ltd (“Link”), a UK-based pharmaceuticals group with commercial operations in the UK, France and Germany.
As a result of the acquisition, Link will become the UK commercial organisation for Archimedes, whilst the French and German operations will form the basis of Archimedes’ European commercial operations.
Bird & Bird advised Archimedes on all the intellectual property provisions of the deal. This also included an entire review of the intellectual property relating to Link’s product range which is sold across a number of European jurisdictions. A London team of partner Gerry Kamstra, assisted by Ewan Grist, Hayley French and also partner Sally Shorthose were involved.
Commenting on the firm’s involvement, Richard de Souza, CEO of Archimedes Pharma said:
“We were delighted with Bird & Bird’s involvement. The transaction required lawyers with expert intellectual property knowledge not just of UK law but also of the relevant countries in Europe”.
Gerry Kamstra added:
“This is an important deal for Archimedes’s strategy of growing their commercial presence through the acquisition of pharmaceutical companies or products in Europe. We were delighted to have been able to help”.
For more information on this please contact Natalie Arestis, PR Manager on 020 7905 6248.
Notes to Editors
About Bird & Bird
Bird & Bird is a full service international commercial law firm with an in-depth knowledge of chosen industry sectors. We focus on aviation & aerospace, communications, banking & financial services, e-commerce, information technology, life sciences, media and sport. With offices in Beijing, Brussels, Düsseldorf, Frankfurt, The Hague, Hong Kong, London, Lyon, Madrid, Milan, Munich, Paris, Rome and Stockholm, we offer our clients local expertise within a global context helping them to realise their business goals both domestically and internationally.
Bird & Bird was identified as one of the Top 50 Law Firms in the world that has “taken the greatest strides towards globalisation while maintaining quality”, in a recent survey carried out by researchers for the PLCWhich Lawyer? Yearbook.
About Archimedes Pharma
Archimedes is a European specialty pharmaceutical company. Its strategy is to grow its commercial presence through the acquisition of pharmaceutical companies or brands in Europe and through partnering with companies looking for a marketing presence in Europe.
Archimedes will build its own sales and marketing operations in the major European markets. In parallel, Archimedes is developing a robust pipeline of innovative near term products to support its commercial organisation. To drive the company in the medium term, Archimedes has an established development organisation with proprietary technologies for nasal drug delivery and a number of products in development, the most advanced of which could be ready for launch from 2009.
For more information on Archimedes Pharma please go to .